Report Detail

Pharma & Healthcare Global Oral Polio Vaccines (OPV) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3713570
  • |
  • 30 August, 2019
  • |
  • Global
  • |
  • 115 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Scope of the Report:
The worldwide market for Oral Polio Vaccines (OPV) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Oral Polio Vaccines (OPV) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Trivalent OPV
Bivalent OPV

Market Segment by Applications, can be divided into
Public
Private

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Polio Vaccines (OPV) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Polio Vaccines (OPV), with price, sales, revenue and global market share of Oral Polio Vaccines (OPV) in 2017 and 2018.
Chapter 3, the Oral Polio Vaccines (OPV) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Polio Vaccines (OPV) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oral Polio Vaccines (OPV) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oral Polio Vaccines (OPV) sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Oral Polio Vaccines (OPV) Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Trivalent OPV
      • 1.2.2 Bivalent OPV
    • 1.3 Market Analysis by Applications
      • 1.3.1 Public
      • 1.3.2 Private
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Sanofi
      • 2.1.1 Business Overview
      • 2.1.2 Oral Polio Vaccines (OPV) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 GSK
      • 2.2.1 Business Overview
      • 2.2.2 Oral Polio Vaccines (OPV) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 GSK Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Bibcol
      • 2.3.1 Business Overview
      • 2.3.2 Oral Polio Vaccines (OPV) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Bibcol Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Serum Institute
      • 2.4.1 Business Overview
      • 2.4.2 Oral Polio Vaccines (OPV) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Tiantan Biological
      • 2.5.1 Business Overview
      • 2.5.2 Oral Polio Vaccines (OPV) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Panacea Biotec Ltd
      • 2.6.1 Business Overview
      • 2.6.2 Oral Polio Vaccines (OPV) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Bio-Med
      • 2.7.1 Business Overview
      • 2.7.2 Oral Polio Vaccines (OPV) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Halfkin Bio-Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Oral Polio Vaccines (OPV) Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oral Polio Vaccines (OPV) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Oral Polio Vaccines (OPV) Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Oral Polio Vaccines (OPV) Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Oral Polio Vaccines (OPV) Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Oral Polio Vaccines (OPV) Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Oral Polio Vaccines (OPV) Market Analysis by Regions

    • 4.1 Global Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Oral Polio Vaccines (OPV) Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Oral Polio Vaccines (OPV) Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 4.3 Europe Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 4.5 South America Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)

    5 North America Oral Polio Vaccines (OPV) by Country

    • 5.1 North America Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
      • 5.1.1 North America Oral Polio Vaccines (OPV) Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 5.3 Canada Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)

    6 Europe Oral Polio Vaccines (OPV) by Country

    • 6.1 Europe Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Oral Polio Vaccines (OPV) Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 6.3 UK Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 6.4 France Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 6.5 Russia Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 6.6 Italy Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Oral Polio Vaccines (OPV) by Country

    • 7.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2014-2019)
    • 7.2 China Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 7.3 Japan Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 7.4 Korea Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 7.5 India Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)

    8 South America Oral Polio Vaccines (OPV) by Country

    • 8.1 South America Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
      • 8.1.1 South America Oral Polio Vaccines (OPV) Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Oral Polio Vaccines (OPV) by Countries

    • 9.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Oral Polio Vaccines (OPV) Sales and Growth Rate (2014-2019)

    10 Global Oral Polio Vaccines (OPV) Market Segment by Type

    • 10.1 Global Oral Polio Vaccines (OPV) Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Oral Polio Vaccines (OPV) Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Oral Polio Vaccines (OPV) Revenue and Market Share by Type (2014-2019)
    • 10.2 Trivalent OPV Sales Growth and Price
      • 10.2.1 Global Trivalent OPV Sales Growth (2014-2019)
      • 10.2.2 Global Trivalent OPV Price (2014-2019)
    • 10.3 Bivalent OPV Sales Growth and Price
      • 10.3.1 Global Bivalent OPV Sales Growth (2014-2019)
      • 10.3.2 Global Bivalent OPV Price (2014-2019)

    11 Global Oral Polio Vaccines (OPV) Market Segment by Application

    • 11.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2014-2019)
    • 11.2 Public Sales Growth (2014-2019)
    • 11.3 Private Sales Growth (2014-2019)

    12 Oral Polio Vaccines (OPV) Market Forecast (2019-2024)

    • 12.1 Global Oral Polio Vaccines (OPV) Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Oral Polio Vaccines (OPV) Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Oral Polio Vaccines (OPV) Market Forecast (2019-2024)
      • 12.2.2 Europe Oral Polio Vaccines (OPV) Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Oral Polio Vaccines (OPV) Market Forecast (2019-2024)
      • 12.2.4 South America Oral Polio Vaccines (OPV) Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Oral Polio Vaccines (OPV) Market Forecast (2019-2024)
    • 12.3 Oral Polio Vaccines (OPV) Market Forecast by Type (2019-2024)
      • 12.3.1 Global Oral Polio Vaccines (OPV) Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Oral Polio Vaccines (OPV) Market Share Forecast by Type (2019-2024)
    • 12.4 Oral Polio Vaccines (OPV) Market Forecast by Application (2019-2024)
      • 12.4.1 Global Oral Polio Vaccines (OPV) Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Oral Polio Vaccines (OPV) Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Oral Polio Vaccines (OPV). Industry analysis & Market Report on Oral Polio Vaccines (OPV) is a syndicated market report, published as Global Oral Polio Vaccines (OPV) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Oral Polio Vaccines (OPV) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,818.80
      4,228.20
      5,637.60
      3,267.72
      4,901.58
      6,535.44
      538,564.80
      807,847.20
      1,077,129.60
      290,232.00
      435,348.00
      580,464.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report